Home Tags Valeant Pharmaceuticals
Tag: Valeant Pharmaceuticals
Investors in Allergan Pharmaceuticals are suing Ackman and Valeant over their 2014 attempted hostile takeover of the company.
We've seen some marvelous example of Wall Street spin, and we're gonna hear more if the market doesn't improve for hedge funds.
The rich often grow their money through family offices. A Wall Street Journal report highlights how that can sometimes pose a conflict.
Bill, this is growth.
Of course, "average" is $801 million — so we're talking about the big boys here.
Valeant Pharmaceuticals' stock price has been falling over the past year and a half. Here are the events that punctuated that demise.
According to CNBC's David Faber, Bill Ackman has exited his once darling stock, Valeant Pharmaceuticals.
Valeant Pharmaceuticals has fallen 20% over the last week.
There could be a million reasons, take your pick.